From July 1, 2022 to December 31, 2022, the company has repurchased 12,078,000 shares, representing 2.94% for HKD 18.44 million. With this, the company has completed the repurchase of 13,412,000 shares, representing 3.28% for HKD 20.54 million under the buyback announced on June 24, 2022.
Lansen Pharmaceutical Holdings Limited
Equities
503
KYG5380M1033
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+25.54% | 661B | |
+26.74% | 566B | |
-6.60% | 352B | |
+19.87% | 332B | |
+3.09% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-5.34% | 145B |